Icon

BRIDION (nda022225)- (EQ 500MG BASE/5ML (EQ 100MG BASE/ML),EQ 200MG BASE/2ML (EQ 100MG BASE/ML))

SUGAMMADEX SODIUM MSD SUB MERCK
EQ 500MG BASE/5ML (EQ 100MG BASE/ML),EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Yes No
2026-Jan-27 2020-Dec-15
None None
None No
BRIDION is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery.
4 9 1
Total Other Developers 32
Drugs with Suitability No
EQ 500MG BASE/5ML (EQ 100MG BASE/ML) ** ** - - -
EQ 200MG BASE/2ML (EQ 100MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** ******* *********** ****** **. ***, ******* ****, ***** ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.